ClinicalTrials.gov
ClinicalTrials.gov Menu

Registry of Translarna (Ataluren) in Nonsense Mutation Duchenne Muscular Dystrophy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02369731
Recruitment Status : Recruiting
First Posted : February 24, 2015
Last Update Posted : February 14, 2017
Sponsor:
Collaborators:
TREAT-NMD
Cooperative International Neuromuscular Research Group (CINRG)
Information provided by (Responsible Party):
PTC Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : April 2022
  Estimated Study Completion Date : April 2022